vs

Side-by-side financial comparison of Purple Innovation, Inc. (PRPL) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.

Purple Innovation, Inc. is the larger business by last-quarter revenue ($140.7M vs $70.6M, roughly 2.0× Viridian Therapeutics, Inc.\DE). Purple Innovation, Inc. runs the higher net margin — -2.3% vs -49.0%, a 46.7% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 9.1%). Purple Innovation, Inc. produced more free cash flow last quarter ($-7.8M vs $-84.7M).

Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”

Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.

PRPL vs VRDN — Head-to-Head

Bigger by revenue
PRPL
PRPL
2.0× larger
PRPL
$140.7M
$70.6M
VRDN
Growing faster (revenue YoY)
VRDN
VRDN
+81949.1% gap
VRDN
81958.1%
9.1%
PRPL
Higher net margin
PRPL
PRPL
46.7% more per $
PRPL
-2.3%
-49.0%
VRDN
More free cash flow
PRPL
PRPL
$76.9M more FCF
PRPL
$-7.8M
$-84.7M
VRDN

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
PRPL
PRPL
VRDN
VRDN
Revenue
$140.7M
$70.6M
Net Profit
$-3.2M
$-34.6M
Gross Margin
41.9%
Operating Margin
-1.6%
-56.7%
Net Margin
-2.3%
-49.0%
Revenue YoY
9.1%
81958.1%
Net Profit YoY
62.1%
54.9%
EPS (diluted)
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRPL
PRPL
VRDN
VRDN
Q4 25
$140.7M
Q3 25
$118.8M
$70.6M
Q2 25
$105.1M
Q1 25
$104.2M
Q4 24
$129.0M
Q3 24
$118.6M
Q2 24
$120.3M
Q1 24
$120.0M
Net Profit
PRPL
PRPL
VRDN
VRDN
Q4 25
$-3.2M
Q3 25
$-11.7M
$-34.6M
Q2 25
$-17.3M
Q1 25
$-19.1M
Q4 24
$-8.5M
Q3 24
$-39.2M
Q2 24
$27.0K
Q1 24
$-50.2M
Gross Margin
PRPL
PRPL
VRDN
VRDN
Q4 25
41.9%
Q3 25
42.8%
Q2 25
35.9%
Q1 25
39.4%
Q4 24
42.9%
Q3 24
29.7%
Q2 24
40.7%
Q1 24
34.8%
Operating Margin
PRPL
PRPL
VRDN
VRDN
Q4 25
-1.6%
Q3 25
-10.2%
-56.7%
Q2 25
-13.5%
Q1 25
-13.9%
Q4 24
-6.0%
Q3 24
-39.5%
Q2 24
-12.1%
Q1 24
-19.3%
Net Margin
PRPL
PRPL
VRDN
VRDN
Q4 25
-2.3%
Q3 25
-9.9%
-49.0%
Q2 25
-16.5%
Q1 25
-18.4%
Q4 24
-6.6%
Q3 24
-33.1%
Q2 24
0.0%
Q1 24
-41.8%
EPS (diluted)
PRPL
PRPL
VRDN
VRDN
Q4 25
$0.03
Q3 25
$0.11
Q2 25
$0.16
Q1 25
$0.18
Q4 24
$0.08
Q3 24
$0.36
Q2 24
$0.00
Q1 24
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRPL
PRPL
VRDN
VRDN
Cash + ST InvestmentsLiquidity on hand
$24.3M
$490.9M
Total DebtLower is stronger
$126.7M
Stockholders' EquityBook value
$-29.7M
$503.0M
Total Assets
$296.3M
$577.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRPL
PRPL
VRDN
VRDN
Q4 25
$24.3M
Q3 25
$32.4M
$490.9M
Q2 25
$34.2M
Q1 25
$21.6M
Q4 24
$29.0M
Q3 24
$23.4M
Q2 24
$23.4M
Q1 24
$34.5M
Total Debt
PRPL
PRPL
VRDN
VRDN
Q4 25
$126.7M
Q3 25
Q2 25
Q1 25
Q4 24
$70.7M
Q3 24
$50.8M
Q2 24
Q1 24
Stockholders' Equity
PRPL
PRPL
VRDN
VRDN
Q4 25
$-29.7M
Q3 25
$-26.9M
$503.0M
Q2 25
$-15.6M
Q1 25
$1.3M
Q4 24
$20.2M
Q3 24
$28.0M
Q2 24
$66.4M
Q1 24
$65.5M
Total Assets
PRPL
PRPL
VRDN
VRDN
Q4 25
$296.3M
Q3 25
$302.1M
$577.1M
Q2 25
$303.8M
Q1 25
$293.8M
Q4 24
$307.8M
Q3 24
$309.3M
Q2 24
$362.1M
Q1 24
$382.1M
Debt / Equity
PRPL
PRPL
VRDN
VRDN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
3.50×
Q3 24
1.82×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRPL
PRPL
VRDN
VRDN
Operating Cash FlowLast quarter
$-5.8M
$-84.6M
Free Cash FlowOCF − Capex
$-7.8M
$-84.7M
FCF MarginFCF / Revenue
-5.5%
-120.1%
Capex IntensityCapex / Revenue
1.4%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRPL
PRPL
VRDN
VRDN
Q4 25
$-5.8M
Q3 25
$-968.0K
$-84.6M
Q2 25
$-4.0M
Q1 25
$-23.1M
Q4 24
$6.8M
Q3 24
$1.1M
Q2 24
$-8.9M
Q1 24
$-16.8M
Free Cash Flow
PRPL
PRPL
VRDN
VRDN
Q4 25
$-7.8M
Q3 25
$-1.8M
$-84.7M
Q2 25
$-7.0M
Q1 25
$-25.3M
Q4 24
$5.7M
Q3 24
$101.0K
Q2 24
$-11.0M
Q1 24
$-19.9M
FCF Margin
PRPL
PRPL
VRDN
VRDN
Q4 25
-5.5%
Q3 25
-1.5%
-120.1%
Q2 25
-6.6%
Q1 25
-24.3%
Q4 24
4.4%
Q3 24
0.1%
Q2 24
-9.2%
Q1 24
-16.5%
Capex Intensity
PRPL
PRPL
VRDN
VRDN
Q4 25
1.4%
Q3 25
0.7%
0.2%
Q2 25
2.8%
Q1 25
2.2%
Q4 24
0.8%
Q3 24
0.9%
Q2 24
1.7%
Q1 24
2.5%
Cash Conversion
PRPL
PRPL
VRDN
VRDN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-330.22×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRPL
PRPL

Cost Of Revenues$81.7M58%
Other$59.0M42%

VRDN
VRDN

Segment breakdown not available.

Related Comparisons